Lisata Therapeutics (8NE) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Gemcitabine, Nab-paclitaxel, Certepetide | Pancreas Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Pancreas Cancer, Pancreatic Carcinoma, Unresectable Pancreatic Cancer, Pdac, Pdac - Pancreatic Ductal Adenocarcinoma | phase1AndPhase2 | Withdrawn | Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC | Sep 09, 2024 | ― |
| Gemcitabine, Durvalumab, Cisplatin, Certepetide, Folfox Regimen | Bile Duct Cancer, Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Gall Bladder Cancer, Gall Bladder Carcinoma, Gallbladder Cancer, Gallbladder Carcinoma, Extrahepatic Cholangiocarcinoma | Phase II | Active Not Recruiting | A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors | Jan 26, 2023 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Gemcitabine, Nab-paclitaxel, Certepetide | phase1AndPhase2 | Pancreas Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Pancreas Cancer, Pancreatic Carcinoma, Unresectable Pancreatic Cancer, Pdac, Pdac - Pancreatic Ductal Adenocarcinoma | Withdrawn | Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC | Sep 09, 2024 | ― |
| Gemcitabine, Durvalumab, Cisplatin, Certepetide, Folfox Regimen | Phase II | Bile Duct Cancer, Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Gall Bladder Cancer, Gall Bladder Carcinoma, Gallbladder Cancer, Gallbladder Carcinoma, Extrahepatic Cholangiocarcinoma | Active Not Recruiting | A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors | Jan 26, 2023 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Lisata Therapeutics, Inc. (DE:8NE) have in its pipeline
Lisata Therapeutics DE:8NE is currently developing the following drugs: Gemcitabine, Nab-paclitaxel, Certepetide, Gemcitabine, Durvalumab, Cisplatin, Certepetide, Folfox Regimen. These drug candidates are in various stages of clinical development as the company works toward FDA approval.